Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curatio Healthcare is a prominent Indian pharmaceutical company specializing in the dermatology and pediatric skin care segments. Established in 2005, the company has developed a robust portfolio of over 50 brands, including market leaders like Tedibar, Atogla, and Spoo. Curatio focuses on providing high-quality, research-driven solutions for conditions such as atopic dermatitis, acne, and fungal infections. In 2022, the company was acquired by Torrent Pharmaceuticals for approximately $245 million, significantly expanding Torrent's presence in the dermatology market. Curatio's products are widely recognized and prescribed by medical professionals across India and several international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curatio Healthcare.